In Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Bacopa monnieri has been used in Ayurvedic medicine to improve memory and cognition. The active constituent responsible for its pharmacological effects is bacoside A, a mixture of dammarane-type triterpenoid saponins containing sugar chains linked to a steroid aglycone skeleton. Triterpenoid saponins have been reported to be transformed in vivo to metabolites that give better biological activity and pharmacokinetic characteristics. Thus, the activities of the parent compounds (bacosides), aglycones (jujubogenin and pseudojujubogenin) and their derivatives (ebelin lactone and bacogenin A1) were compared using a combination of in silico and in vitro screening methods. The compounds were docked into 5-HT1A, 5-HT2A, D1, D2, M1 receptors and acetylcholinesterase (AChE) using AutoDock and their central nervous system (CNS) drug-like properties were determined using Discovery Studio molecular properties and ADMET descriptors. The compounds were screened in vitro using radioligand receptor binding and AChE inhibition assays. In silico studies showed that the parent bacosides were not able to dock into the chosen CNS targets and had poor molecular properties as a CNS drug. In contrast, the aglycones and their derivatives showed better binding affinity and good CNS drug-like properties, were well absorbed through the intestines and had good blood brain barrier (BBB) penetration. Among the compounds tested in vitro, ebelin lactone showed binding affinity towards M1 (Ki = 0.45 μM) and 5-HT2A (4.21 μM) receptors. Bacoside A and bacopaside X (9.06 μM) showed binding affinity towards the D1 receptor. None of the compounds showed any inhibitory activity against AChE. Since the stimulation of M1 and 5-HT2A receptors has been implicated in memory and cognition and ebelin lactone was shown to have the strongest binding energy, highest BBB penetration and binding affinity towards M1 and 5-HT2A receptors, we suggest that B. monnieri constituents may be transformed in vivo to the active form before exerting their pharmacological activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pyramidal neurons: dendritic structure and synaptic integration
Spruston, N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2286 · Cited by 1,688
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Megı́as, M., Emri, Z., Freund, T. F., & Gulyás, A. I. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00496-6 · Cited by 950
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529 · cited 1×
“In addition, the location of 5-HT2A receptors in the cortex and hippocampus on cholinergic [72] and glutamatergic [73] axon terminals serves to regulate the release of these transmitters where the increased release of acetylcholine and glutamate are expected to enhance learning [33].”
BackgroundGlycosides in Medicine: “The Role of Glycosidic Residue in Biological Activity”
Kren, V., & Martinkova, L. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372193 · Cited by 475
Bacopa monniera, a reputed nootropic plant: An overview
Russo, A., & Borrelli, F. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.12.008 · Cited by 447 · cited 1×
“monnieri include antiepileptic, anxiolytic, antidepressant, sedative, antioxidant and anti-inflammatory activities [4].”
BackgroundMuscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
Neuropharmacological Review of the Nootropic Herb Bacopa monnieri
Aguiar, S., & Borowski, T. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1431 · Cited by 295 · cited 1×
“Various mechanisms of action for its cognitive effects have been proposed including acetylcholinesterase (AChE) inhibition, β-amyloid reduction, antioxidant neuroprotection, neurotransmitter modulation (acetylcholine [ACh], 5-hydroxytryptamine [5-HT], dopamine [DA]), choline acetyltransferase activation and increased…”
BackgroundA comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba
Das, A., Shanker, G., Nath, C., Pal, R., Singh, S., & Singh, H. K. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00940-1 · Cited by 264
Yamasaki, M., Matsui, M., & Watanabe, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5719-09.2010 · Cited by 203
Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract
Kongkeaw, C., Dilokthornsakul, P., Thanarangsarit, P., Limpeanchob, N., & Norman Scholfield, C. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.008 · Cited by 188 · cited 1×
“monnieri has the potential to improve cognition [3].”
BackgroundQuantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC
Deepak, M., Sangli, G. K., Arun, P. C., & Amit, A. (2005) · Phytochemical Analysis · doi:10.1002/pca.805 · Cited by 164 · cited 1×
“Bacoside A is a mixture of four triglycosidic saponins, namely bacoside A3, bacopaside II, bacopasaponin C and the jujubogenin isomer of bacosaponin C (bacopaside X) [9].”
BackgroundEffect of bacosides A and B on avoidance responses in rats
Singh, H. K., Rastogi, R. P., Srimal, R. C., & Dhawan, B. N. (1988) · Phytotherapy Research · doi:10.1002/ptr.2650020205 · Cited by 163
Bhattacharya, S. K., Kumar, A., & Ghosal, S. (1995) · Phytotherapy Research · doi:10.1002/ptr.2650090206 · Cited by 112
Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex
Quirion, R., Richard, J., & Dam, T. V. (1985) · Brain Research · doi:10.1016/0006-8993(85)91590-2 · Cited by 88
Rastogi, M., Ojha, R. P., Prabu, P. C., Devi, B. P., Agrawal, A., & Dubey, G. P. (2012) · Biogerontology · doi:10.1007/s10522-011-9367-y · Cited by 71 · cited 1×
“Treatment with bacosides on aged rats for a 3 months period appeared to enhance the synthesis and availability of acetylcholine rather than affecting the activity of AChE [85].”
BackgroundBarbhaiya, H. C., Desai, R. P., Saxena, V. S., Pravina, K., Wasim, P., Geetharani, P., Allan, J. J., Venkateshw, K., & Amit, A. (2008) · Journal of Pharmacology and Toxicology · doi:10.3923/jpt.2008.425.434 · Cited by 54 · cited 1×
“monnieri [60–63].”
Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents
Ramasamy, S., Kiew, L., & Chung, L. (2014) · Molecules · doi:10.3390/molecules19022588 · Cited by 47 · cited 1×
“monnieri extracts inhibit some human cytochrome P450 (CYP) drug metabolizing enzymes [16].”
BackgroundSelf-citationPharmacological studies on bacopa monniera, an Ayurvedic nootropic agent
Dhawan, B. N., & Singh, H. K. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87969-7 · Cited by 37
Cited by
Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease
Dubey, T., & Chinnathambi, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108153 · Cited by 151
Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature
Tang, S. W., Tang, W. H., & Leonard, B. E. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1346279 · Cited by 11
Arora, R., Kumar, R., Agarwal, A., & Gupta, Y. K. (2021) · Natural Product Research · doi:10.1080/14786419.2020.1817919
Metadata
- Authors
- Ramasamy, S., Chin, S. P., Sukumaran, S. D., Buckle, M. J. C., Kiew, L. V., & Chung, L. Y.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-05-12
- Volume
- 10
- Issue
- 5
- Pages
- e0126565
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W878946039
- Cited by
- 95
- References
- 20
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.